Spectrum, the Stanford Center for Clinical and Translational Education and Research, is part of a national consortium that includes over 60 recipients of the Clinical and Translational Science Awards (CTSA), established by the National Institutes of Health (NIH).
Spectrum’s core mission is to streamline, accelerate, and promote the translation of basic discoveries into practical solutions that improve human health. Working across Stanford University, Spectrum supports this mission through education programs, research support and infrastructure, innovation funding, and consortium collaborations.
Resources and Services
Spectrum provides a wide range of resources and services to support translational research, including:
- Biostatistics & Study Design
- Clinical & Translational Research Unit (CTRU)
- Career Development & Diversity
- Child Health
- Clinical Informatics
- Community Engagement
- Enabling Technologies
- Innovations & Pilots
- Operations, Training & Compliance
- Research Education & Training
- Tracking & Evaluation
Harry B. Greenberg, MD, the Joseph D. Grant Professor of Medicine and Microbiology and Immunology has served as the Spectrum Program Director since Spectrum’s inception in 2008. As Director of Spectrum, he reports directly to the University Vice Provost and Dean of Research (Dr. Ann Arvin). As the Senior Associate Dean for Research he reports directly to the Dean of the School of Medicine (Dr. Lloyd Minor).
Dr. Greenberg is a well-recognized experimental medicine researcher. He maintains an active and well funded research lab focused on rotavirus and influenza pathogenesis and immunity. His research interests over the past 40 years have been on important viral infections of humans, with emphasis on viral pathogenesis, immunity and vaccination. He has studied hepatitis B virus (HBV), Norwalk virus, rotavirus, hepatitis C virus (HCV), and recently, influenza virus. He was an inventor of the first effective rotavirus vaccine and spent a two-year leave of absence from Stanford in the biotechnology industry working on bringing the live, attenuated influenza vaccine (FluMistR) to licensure. Dr. Greenberg is a fellow of the American Association for the Advancement of Science, a member of the American Society for Clinical Investigation and a member of the Association of American Physicians. He is the past president of the American Society of Virology. He is a member of the IOM Drug Forum and a past member of the National Academy of Science Standing Committee on DoD Biodefense.
Spectrum Executive Committee
Philip Lavori, PhD, Professor of Biostatistics, is responsible for the design, administration and assessment of the biostatistics, clinical informatics, study design and bioethics components of Spectrum. He is a prominent leader in the field of clinical study design. His focus over the last 20 years has been on innovations in the design of randomized clinical trials. Dr. Lavori is one of the founders of the field of trial design for adaptive treatment strategies.
Charles Prober, MD, Professor of Pediatrics (Infectious Disease) and Microbiology & Immunology, is responsible for the education and training components of the CTSA. He brings considerable translational research knowledge and accomplishments, clinical research administrative experiences, leadership skills and dedication to the mentoring and training of undergraduates, medical students, residents and clinical fellows to Spectrum. Dr. Prober’s research has included epidemiologic and clinical trial studies focused on pediatric infectious diseases.
Branimir I. (Brandy) Sikic, MD, Professor of Medicine in the Division of Oncology, is responsible for the Clinical Research Services of Spectrum and serves to help coordinate Spectrum resources and services with those of our NIH-funded Cancer Center. He is an expert in the biology of anticancer drug resistance, the development of new cancer therapies and early phase translational trials. His current work includes studies on mechanisms of resistance to taxane drugs and genomic approaches to tumor classification.
David Stevenson, MD, the Harold K. Faber Professor of Pediatrics and Chief of the Division of Neonatal and Developmental Medicine, is responsible for the administration and assessment of all child health research programs in Spectrum. In addition to his research accomplishments in the field of neonatology, he established the California Association of Neonatology (CAN) and the California Perinatal Quality Care Collaborative (CPQCC). He served as President of the American Pediatric Society from 2005 to 2006.
Spectrum Program Leaders
- Steven R. Alexander, MD – Leader, Operations, Training & Compliance
- Mary Chen, MS, MBA – Director, Child Health
- Mildred Cho, PhD – Co-Leader, Bioethics
- Steven Goodman, MD, PhD – Leader, Research Education & Training
- Philip Lavori, PhD – Leader, Biostatistics and Study Design
- Henry Lowe, MD – Leader, Clinical Informatics
- Rhonda McClinton-Brown, MPH – Co-Leader, Community Engagement
- David Magnus, PhD – Co-Leader, Bioethics
- Daria Mochly-Rosen, PhD – Co-Leader, Innovations & Pilots; Co-Leader, Enabling Technologies
- Christy Sandborg, MD – Co-Leader, Child Health
- Branimir I. (Brandy) Sikic, MD – Leader, Clinical & Translational Research Unit (CTRU)
- David Stevenson, MD – Leader, Child Health; Co-Leader, Clinical & Translational Research Unit (CTRU)
- Paul Yock, MD – Co-Leader, Innovations & Pilots; and Co-Leader, Enabling Technologies
- Hannah Valantine, MD – Leader, Career Development & Diversity
- Chris Webb, PhD – Executive Director
- Marilyn Winkleby, PhD, MPH – Leader, Community Engagement
Starting a Clinical Study?
Study Navigator is a study management tool for researchers for developing and conducting clinical trials or human studies at Stanford. Use Study Navigator to Schedule Consultations, Download Tools, Update Studies.Login to get started